Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by Amryt Pharma plc Chiesi Farmaceutici S.p.A. Completes Acquisition of Amryt Pharma Plc April 12, 2023 From Amryt Pharma plc Via GlobeNewswire Tickers AMYT High Court of Justice of England and Wales Sanctions Scheme of Arrangement April 03, 2023 From Amryt Pharma plc Via GlobeNewswire Tickers AMYT Amryt Pharma Shareholders approve acquisition of Amryt Pharma by Chiesi Farmaceutici March 22, 2023 From Amryt Pharma plc Via GlobeNewswire Tickers AMYT AMRYT PUBLISHES SCHEME CIRCULAR AND ANNOUNCES THE SHAREHOLDER MEETINGS TO CONSIDER AND VOTE ON THE CHIESI ACQUISITION WILL BE HELD ON MARCH 22, 2023 February 16, 2023 From Amryt Pharma plc Via GlobeNewswire Tickers AMYT Chiesi Farmaceutici S.p.A. to Acquire Amryt Pharma Plc January 08, 2023 From Amryt Pharma plc Via GlobeNewswire Tickers AMYT Amryt Announces Positive Top Line Results from Phase 3 Pediatric Trial of Lomitapide in HoFH January 05, 2023 From Amryt Pharma plc Via GlobeNewswire Tickers AMYT COMP Adopts Positive Opinion on Orphan Designation for Mycapssa® for the Treatment of Carcinoid Syndrome Associated with Neuroendocrine Tumors December 19, 2022 From Amryt Pharma plc Via GlobeNewswire Tickers AMYT European Commission approves Mycapssa® for the treatment of Acromegaly December 05, 2022 From Amryt Pharma plc Via GlobeNewswire Tickers AMYT Amryt Announces New Patent for Mycapssa® November 30, 2022 From Amryt Pharma plc Via GlobeNewswire Tickers AMYT Amryt Reports Q3 2022 Financial and Operational Results November 03, 2022 From Amryt Pharma plc Via GlobeNewswire Tickers AMYT Amryt Supports Acromegaly Awareness Day 2022 October 31, 2022 From Amryt Pharma plc Via GlobeNewswire Tickers AMYT The British Journal of Dermatology Publishes Results from Amryt’s EASE Phase 3 Trial in Epidermolysis Bullosa October 25, 2022 From Amryt Pharma plc Via GlobeNewswire Tickers AMYT Amryt Supports Global EB Awareness Week 2022 October 24, 2022 From Amryt Pharma plc Via GlobeNewswire Tickers AMYT Amryt to Report Q3 2022 Results on November 3, 2022 October 19, 2022 From Amryt Pharma plc Via GlobeNewswire Tickers AMYT COMP adopts positive opinion on Orphan Disease Designation for Mycapssa® for the treatment of Acromegaly October 18, 2022 From Amryt Pharma plc Via GlobeNewswire Tickers AMYT Amryt Receives Reimbursement Approval from the Dutch Ministry of Health for Myalepta® (metreleptin) October 17, 2022 From Amryt Pharma plc Via GlobeNewswire Tickers AMYT Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.